Back to search

New strategies in the treatment of early Parkinson's disease

Data up to Jan 2025

Published1991
Citations13
References24

Total Citations Per Year

Abstract

References (24)

Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease

1989 • 913 citations

The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease

1989 • 621 citations

Striatal inhomogeneities and basal ganglia function

1986 • 323 citations

Lisuride and Other Dopamine Agonists

1983 • 198 citations

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease

1987 • 168 citations

Deprenyl (selegiline): the history of its development and pharmacological action

1983 • 159 citations

Multi‐center study of Parkinson mortality with early versus later dopa treatment

1987 • 148 citations

Lisuride, a dopamine agonist in the treatment of early Parkinson's disease

1989 • 131 citations

Combined bromocriptine-levodopa therapy early in Parkinson's disease

1985 • 115 citations

Long‐term follow‐up of early dopa treatment in Parkinson's disease

1986 • 107 citations

Factors that influence the occurrence of response variations in Parkinson's disease

1987 • 106 citations

Problems associated with long-term levodopa treatment of Parkinson's disease

1983 • 95 citations

Oxidative Stress in the Nervous System

1985 • 73 citations

Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease

1991 • 62 citations

Selegiline in the treatment of Parkinson's disease

1989 • 56 citations

Treatment of Parkinson's disease: Problems with a progressing disease

1981 • 48 citations

Early dopamine agonist therapy in Parkinson's disease

1989 • 41 citations

Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson's disease

2009 • 40 citations

Selegiline as primary treatment in early phase Parkinson's disease - an interim report

1989 • 35 citations

Tolerance of tetrabenazine during long-term treatment

1983 • 24 citations

Combination of a dopamine agonist, MAO-B inhibitor and levodopa - a new strategy in the treatment of early Parkinson's disease

1989 • 21 citations

Treatment of early Parkinson's disease with controlled-release levodopa preparations.

1989 • 11 citations

Levodopa in Parkinson's disease: effect on mortality

2009 • 10 citations

Controversies in the management of Parkinson's disease

1986 • 8 citations

Cited By (0)

Loading...
New strategies in the treatment of early Parkinson's disease (1991) – Acta Neurologica Scandinavica | Metascience Observatory Explorer